Amid IPO rumors, this biotech unicorn lands ex-Bayer exec as fourth CEO in 22 months By: San Francisco Business Times via Business Journals June 10, 2019 at 17:25 PM EDT Hans Bishop was at Chiron, Bayer and led Juno Therapeutics through its $9 billion acquisition last year by Celgene. Read More >>
